Mitochondrial Bioenergetics and Quality Control Mechanisms in Health and Disease

Julio C B Ferreira^{1

2}, Marcelo A Mori³, Eric R Gross⁴

Affiliations

¹ Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil.
² School of Medicine, University of Sao Paulo, SP, Brazil.
³ Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (Unicamp), SP, Brazil.
⁴ Department of Anesthesiology, Stanford University School of Medicine, Stanford, California, USA.

Editorial

Julio C B Ferreira et al. Oxid Med Cell Longev. 2019.

. 2019 Jan 20:2019:5406751.

doi: 10.1155/2019/5406751. eCollection 2019.

Julio C B Ferreira^{1

2}, Marcelo A Mori³, Eric R Gross⁴

¹ Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil.
² School of Medicine, University of Sao Paulo, SP, Brazil.
³ Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (Unicamp), SP, Brazil.
⁴ Department of Anesthesiology, Stanford University School of Medicine, Stanford, California, USA.

No abstract available

References

1. Campos J. C., Bozi L. H. M., Bechara L. R. G., Lima V. M., Ferreira J. C. B. Mitochondrial quality control in cardiac diseases. Frontiers in Physiology. 2016;7:p. 479. doi: 10.3389/fphys.2016.00479. - DOI - PMC - PubMed
1. Kiyuna L. A., Albuquerque R. P., Chen C. H., Mochly-Rosen D., Ferreira J. C. B. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities. Free Radical Biology & Medicine. 2018;129:155–168. doi: 10.1016/j.freeradbiomed.2018.09.019. - DOI - PMC - PubMed
1. Ueta C. B., Gomes K. S., Ribeiro M. A., Mochly-Rosen D., Ferreira J. C. B. Disruption of mitochondrial quality control in peripheral artery disease: new therapeutic opportunities. Pharmacological Research. 2017;115:96–106. doi: 10.1016/j.phrs.2016.11.016. - DOI - PMC - PubMed
1. Fernandes T., Bechara L. R. G., da Paixão N. A., Brum P. C., de Oliveira E. M., Ferreira J. C. B. Increased clearance of reactive aldehydes and damaged proteins in hypertension-induced compensated cardiac hypertrophy: impact of exercise training. Oxidative Medicine and Cellular Longevity. 2015;2015:11. doi: 10.1155/2015/464195.464195 - DOI - PMC - PubMed
1. Sun L., Ferreira J. C., Mochly-Rosen D. ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Science Translational Medicine. 2011;3(107, article 107ra111) doi: 10.1126/scitranslmed.3002067. - DOI - PMC - PubMed